A new global hypertension complex ‘Amosartan’ acquired a patent in Japan

The Hanmi Pharmaceutical’s (executive director Kwan-soon Lee)new global hypertension complex ‘Amosartan’has acquired a composite patent (application number: JP2011547746) in Japan.

‘Amosartan’ is a new complexof ARB type (Losartan) and CCB type (Amlodipine) hypertension treatments with two different medicinal fundamentals; the patent is a technology improving effectiveness and safety through m...